Viral drug resistance

Drug resistance is reduced susceptibility to a drug in a laboratory culture system which  is determined by specific mutations in the viral genome that leads to alterations in the viral target protein (for example, HIV reverse transcriptase) or the viral drug activator. 

  • The problem of viral drug resistance
  • Potential methods to overcome this

Related Conference of Viral drug resistance

February 24-25, 2020

7th International Congress on Infectious Diseases

Berlin, Germany
April 27-28, 2020

7th Global Congress on Rare Diseases & Orphan Drug

Istanbul, Turkey
June 09-10, 2020

10th European Epidemiology and Public Health Congress

Istanbul, Turkey
July 22-23, 2020

10th World Congress on Rare Diseases and Orphan Drugs

Barcelona, Spain
August 19-20, 2020

European Summit on HIV, STD and STIs

Milan, Italy
September 28-29, 2020

13th Global Infections Conference

Singapore
September 28-29, 2020

World Congress on Infectious Diseases and Rare Diseases

Osaka, Japan
October 5-6, 2020

12th Euro-Global Conference on Infectious Diseases

Vienna, Austria

Viral drug resistance Conference Speakers

Recommended Sessions

Related Journals

Are you interested in